Sharechat Logo

SmartPay gets approval for ASX listing, capital raising

Friday 29th June 2012

Text too small?

Shareholders of SmartPay, the eftpos terminal company, voted in favour of a capital raising programme that will see it list on the Australian Stock Exchange. Shareholders were offered 11.5 cents apiece under a capital raising plan which will see the company list on the ASX by the end of the year. It will remain listed in the NZX.

"We are already seeing the early signs of the benefits of the restructure reflecting in the business," Bradley Gerdis, chief executive said in a statement. “In Australia our growth pipeline continues to build but progress to date has been restrained by the previous lack of capital and resource."

"With our funding now in place we can now start to resource to execute on these opportunities,” he said. SmartPay announced in May it was appointing a new chairman, Australian businessman Ivan Hammerschlag as chairman.

Gerdis also joined the board as managing director. In February SmartPay ditch its securitisation funding model in favour of “conventional bank funding” in a bid to cut costs after it full-year earnings before interest, tax, depreciation and amortisation will miss the $7.2 million guidance issued in December. Shares in SmartPay are currently trading at 12.5 cents.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report